iPSCs Manufacturing Services Market Size is valued at USD 1.3 billion in 2024 and is predicted to reach USD 4.6 billion by the year 2034 at a 14.1 % CAGR during the forecast period for 2025-2034.
Induced Pluripotent Stem Cells (iPSC) are originated from skin or blood cells. iPSCs are cells that are reprogrammed from somatic cells using different transcription factors. These cells are pluripotent, have the potential for self-renewal, and can differentiate into any of the 220+ human cell types. iPSC has certain advantages over other stem cell types in regenerative medicine and wound healing models. iPSCs are used to produce patient-specific cells, which can be transplanted to the site of injury or tissue degeneration due to various disease conditions. iPS cells have the potential to become embryos if exposed to suitable conditions. Some important characteristics of iPSC are abundant somatic cells of the donor that can be used. Issues of histocompatibility with donor/recipient transplants can be avoided. Very useful for drug development and developmental studies.
Market growth factors are increasing research on personalized or precise medicine and extended applications in regenerative treatments and therapies due to the high therapeutic potential of iPS cells. Uprising trials and research on diseases like Parkinson's disease, Anemia, and cardiac syndromes will contribute to iPSC production. In the manufacturing of iPS cells, the use of an automated platform will boost the market with cost reduction and increased output. In Apr 2022, Ncardia launched a new business, Cellistic™, to focus Ncardia's induced pluripotent stem cell (iPSC) expertise on cell therapy development and manufacturing. Affordable cost for cell therapy and demonstration of these therapies' safety and efficacy are market restraining factors. Also, methods for ensuring reproducibility and maintenance, as differentiated tissues are uncertain, are expected to hamper the market growth. The standard technique to create iPS cells uses viruses to transfer the reprogramming genes into the skin cells, which is one of iPS cells' cons.
Tumorigenicity, immune rejection, phenotypic heterogeneity of therapeutic cell products and genetic instability are prime challenges in stem cell research that will impact the production of iPS Cells.
iPSCs manufacturing services market is segmented into two main fragments. As per the service type segment, the market is divided into iPSCs Generation, iPSCs Differentiation, iPSCs Characterization and Quality Control, iPSCs Banking, and Others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, Latin America, & the Middle East and Africa.
North America is likely to witness rapid growth in the forecast period, followed by Europe due to fast research on cardiac diseases, neuropathies and personalized medicine production. Also, significant funding for development in iPSC manufacturing will be responsible for the growth.
Report Attribute |
Specifications |
Market Size Value In 2024 |
USD 1.3 Billion |
Revenue Forecast In 2034 |
USD 4.6 Billion |
Growth Rate CAGR |
CAGR of 14.1 % from 2025 to 2034 |
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
Historic Year |
2021 to 2024 |
Forecast Year |
2025-2034 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Application, By End-User, Service Type |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
Competitive Landscape |
I Peace Inc., Lonza Group AG, Axol Bioscience Ltd., FUJIFILM Cellular Dynamics, Inc., Pluristyx, Inc., Ncardia, Cynata Therapeutics Limited, Evotec SE, Celogics Inc, Catalent, Inc, CCRM, Applied StemCell Inc. (ASC), RoslinCT, Takara Bio Inc, Thermo Fisher Scientific, Inc, Other Prominent Players |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global iPSCs Manufacturing Services Market Snapshot
Chapter 4. Global iPSCs Manufacturing Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By End-Users Estimates & Trend Analysis
5.1. By End-Users & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-Users:
5.2.1. Pharmaceutical & Biotechnology Companies
5.2.2. Academic institutes, Research Laboratories & CROs
5.2.3. Hospitals & Surgical Centres
5.2.4. Cell & Tissue Banks
5.2.5. Other End Users
Chapter 6. Market Segmentation 2: By Applications Estimates & Trend Analysis
6.1. By Applications & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Applications:
6.2.1. Research Products
6.2.2. Drug Development & Discovery
6.2.3. Cellular Service Type
6.2.4. Toxicology Screening
6.2.5. Personalized Medicine
6.2.6. Disease Modelling
6.2.7. Stem Cell Banking
6.2.8. Emerging Applications
Chapter 7. Market Segmentation 3: By Service Type Estimates & Trend Analysis
7.1. By Service Type & Market Share, 2025 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Service Type:
7.2.1. iPSCs Generation
7.2.2. iPSCs Differentiation
7.2.3. iPSCs Characterization and Quality Control
7.2.4. iPSCs Banking
7.2.5. Others
Chapter 8. iPSCs Manufacturing Services Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America iPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts By End-Users, 2021-2034
8.1.2. North America iPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Service Type, 2021-2034
8.1.3. North America iPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Applications, 2021-2034
8.1.4. North America iPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Country, 2021-2034
8.1.4.1. Canada
8.1.4.2. U.S.
8.2. Europe
8.2.1. Europe iPSCs Manufacturing Services Market revenue (US$ Million) By End-Users, 2021-2034
8.2.2. Europe iPSCs Manufacturing Services Market revenue (US$ Million) By Service Type, 2021-2034
8.2.3. Europe iPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Applications, 2021-2034
8.2.4. Europe iPSCs Manufacturing Services Market revenue (US$ Million) by Country, 2021-2034
8.2.4.1. France
8.2.4.2. Germany
8.2.4.3. Italy
8.2.4.4. Spain
8.2.4.5. UK
8.2.4.6. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific iPSCs Manufacturing Services Market revenue (US$ Million) By End-Users, 2021-2034
8.3.2. Asia Pacific iPSCs Manufacturing Services Market revenue (US$ Million) By Service Type, 2021-2034
8.3.3. Asia Pacific iPSCs Manufacturing Services Market revenue (US$ Million) Estimates and forecasts by Applications, 2021-2034
8.3.4. Asia Pacific iPSCs Manufacturing Services Market revenue (US$ Million) by country, 2021-2034
8.3.4.1. Australia
8.3.4.2. China
8.3.4.3. India
8.3.4.4. Japan
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America iPSCs Manufacturing Services Market revenue (US$ Million) By End-Users, 2021-2034
8.4.2. Latin America iPSCs Manufacturing Services Market revenue (US$ Million) By Service Type, 2021-2034
8.4.3. Latin America iPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Applications, 2021-2034
8.4.4. Latin America iPSCs Manufacturing Services Market revenue (US$ Million) by Country, 2021-2034
8.4.4.1. Brazil
8.4.4.2. Mexico
8.4.4.3. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa iPSCs Manufacturing Services Market revenue (US$ Million) By End-Users, 2021-2034
8.5.2. Middle East & Africa iPSCs Manufacturing Services Market revenue (US$ Million) By Service Type, 2021-2034
8.5.3. Middle East & Africa iPSCs Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Applications, 2021-2034
8.5.4. Middle East & Africa iPSCs Manufacturing Services Market revenue (US$ Million) by Country, 2021-2034
8.5.4.1. GCC Countries
8.5.4.2. Rest of MEA
8.5.4.3. South Africa
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. I Peace Inc.
9.2.2. Lonza Group AG
9.2.3. Axol Bioscience Ltd.
9.2.4. FUJIFILM Cellular Dynamics, Inc.
9.2.5. Sartorius AG
9.2.6. Pluristyx Inc.
9.2.7. Ncardia
9.2.8. Cynata Therapeutics Limited
9.2.9. Evotec SE
9.2.10. Celogics Inc
9.2.11. Catalent, Inc
9.2.12. CCRM
9.2.13. (ASC)
9.2.14. RoslinCT
9.2.15. Takara Bio Inc
9.2.16. Thermo Fisher Scientific, Inc
Global iPSCs Manufacturing Services Market, by By Applications,
Global iPSCs Manufacturing Services Market, by End-user,
Global iPSCs Manufacturing Services Market, by Service Type,
Global iPSCs Manufacturing Services Market, by Region,
North America IPSCs Manufacturing Services Market, by Country,
Europe IPSCs Manufacturing Services Market, by Country,
Asia Pacific IPSCs Manufacturing Services Market, by Country,
Latin America IPSCs Manufacturing Services Market, by Country,
Middle East & Africa IPSCs Manufacturing Services Market, by Country,
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.